AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Dividend Announcement
• AstraZeneca Pharma India announced a annually dividend of ₹24.00 per ordinary share which will be made payable on 2024-09-06. Ex dividend date: 2024-07-05
• AstraZeneca Pharma India annual dividend for 2024 was ₹24.00
• AstraZeneca Pharma India annual dividend for 2023 was ₹16.00
• AstraZeneca Pharma India's trailing twelve-month (TTM) dividend yield is 0.36%
AstraZeneca Pharma India Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-05 | ₹24.00 | annually | 2024-09-06 |
2023-07-14 | ₹16.00 | annually | 2023-09-13 |
2022-07-07 | ₹8.00 | annually | 2022-09-06 |
2021-08-18 | ₹2.00 | annually | 2021-09-07 |
2020-08-20 | ₹2.00 | annually | 2020-09-08 |
2019-08-20 | ₹1.00 | annually | 2019-09-04 |
2012-07-09 | ₹3.50 | annually | 2012-08-17 |
2011-07-07 | ₹10.00 | annually | 2011-07-28 |
2010-05-06 | ₹10.00 | annually | 2010-06-19 |
2009-04-29 | ₹15.00 | annually | 2009-06-01 |
2008-04-11 | ₹15.00 | annually | 2008-05-01 |
2007-04-25 | ₹12.00 | annually | |
2007-03-22 | ₹12.00 | annually | 2007-04-01 |
AstraZeneca Pharma India Dividend per year
AstraZeneca Pharma India Dividend growth
AstraZeneca Pharma India Dividend Yield
AstraZeneca Pharma India current trailing twelve-month (TTM) dividend yield is 0.36%. Interested in purchasing AstraZeneca Pharma India stock? Use our calculator to estimate your expected dividend yield:
AstraZeneca Pharma India Financial Ratios
AstraZeneca Pharma India Dividend FAQ
Other factors to consider when evaluating AstraZeneca Pharma India as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy AstraZeneca Pharma India stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: AstraZeneca Pharma India's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, AstraZeneca Pharma India publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, AstraZeneca Pharma India distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from AstraZeneca Pharma India are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: AstraZeneca Pharma India sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, AstraZeneca Pharma India distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: AstraZeneca Pharma India declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of AstraZeneca Pharma India's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review AstraZeneca Pharma India's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.